CALC
CalciMedicaยทNASDAQ
--
--(--)
--
--(--)
CALC Profile
Calcimedica, Inc.
A clinical-stage biotechnology company, focuses on developing therapies for life-threatening inflammatory diseases with unmet needs
505 Coast Boulevard South, Suite 307, La Jolla, California 92037
--
CalciMedica, Inc., was incorporated in February 2015 under the laws of the State of Delaware. The company is a clinical-stage biopharmaceutical company focused on developing therapies for serious diseases driven by inflammation and immune processes as well as direct cell damage. The Company's product candidate acts on the calcium release activated calcium (" CRAC ") channel and will constitute a class of new drugs.
